Table 1. Demographic and Operative Data of Study Groups ^a.

Variable	Study Groups		P Value
	Placebo (n = 30)	Gabapentin (n = 30)
Age, y	35.3 ± 9.2	33.4 ± 5.7	0.3
Sex			0.79
Female	16	17
Male	14	13
BMI b , kg/m 2	44.6 ± 4.5	43.8 ± 4.5	0.5
Surgery Duration, h	5 ± 0.7	5.1 ± 0.9	0.8

^aData are presented as Mean ± SD or No.

^b Body mass index.